Common use
Rizact contains rizatriptan, a serotonin 5‑HT1B/1D receptor agonist in the “triptan” class. It is used for the acute treatment of migraine attacks, with or without aura, in adults and certain pediatric patients. Rizact narrows dilated cranial blood vessels and inhibits release of neuropeptides that drive migraine pain, reducing headache intensity as well as associated symptoms such as nausea, vomiting, sensitivity to light (photophobia), and sound (phonophobia). It is not a preventive therapy and should not be used to reduce the frequency of future attacks.
Many patients experience meaningful relief within 2 hours of a dose, with some noticing benefit as early as 30 minutes. Rizact is available as standard film‑coated tablets and orally disintegrating tablets (ODT) that dissolve on the tongue without water, which can be helpful when nausea or vomiting makes swallowing difficult. It is intended for migraine only; it is not indicated for tension‑type headaches, hemiplegic or basilar migraines, or cluster headaches.
Dosage and direction
Adults: The usual dose is 5 mg or 10 mg taken at the first sign of a migraine. If the headache recurs after initial improvement or does not fully resolve, a second dose may be taken at least 2 hours after the first. Do not exceed 30 mg in a 24‑hour period. Choose the 10 mg dose when stronger relief is needed and you tolerate triptans well; use 5 mg if you are sensitive to medicines or have risk factors that warrant a lower start. Always follow your clinician’s individualized recommendations.
Pediatric patients: For eligible children and adolescents (commonly 6 to 17 years), dosing is weight‑based. A single 5 mg dose may be recommended for patients under 40 kg (88 lb), and a 10 mg dose for those 40 kg or more. The efficacy and safety of a second dose within 24 hours have not been established in pediatric patients; do not repeat unless your clinician specifically advises it.
Patients on propranolol: Propranolol substantially increases rizatriptan levels. If you take propranolol, the recommended dose of Rizact is 5 mg per dose with a maximum of 15 mg in 24 hours. Other beta‑blockers do not appear to have the same interaction, but you should confirm with your prescriber.
How to take: Swallow the standard tablet with water. For the ODT, make sure your hands are dry, peel the foil (do not push the tablet through), place the tablet on the tongue, allow it to dissolve, and swallow with saliva—no water required. Take as soon as migraine pain starts or when aura symptoms are followed by headache; do not pre‑emptively dose during aura without headache unless directed by your clinician. Do not use more than the recommended daily maximum. If your migraine pattern changes or attacks remain disabling despite correct use, seek medical review.
Precautions
Cardiovascular screening: Triptans can cause coronary vasoconstriction. People with risk factors for heart disease (such as men over 40 or postmenopausal women with diabetes, hypertension, smoking, hyperlipidemia, or a strong family history) may need a cardiovascular evaluation before starting Rizact. Stop the medicine and seek urgent care if you experience severe chest pain, shortness of breath, or symptoms suggestive of a heart attack.
Serotonin syndrome: Combining rizatriptan with other serotonergic agents—SSRIs, SNRIs, tricyclics, MAO inhibitors, linezolid, methylene blue, St. John’s wort, certain opioids (e.g., tramadol)—can rarely cause serotonin syndrome. Warning signs include agitation, confusion, sweating, fever, tremor, muscle rigidity, and rapid heart rate. Seek immediate medical attention if these occur.
Blood pressure and vascular issues: Rizact may raise blood pressure. It should be used cautiously in controlled hypertension and is contraindicated in uncontrolled hypertension or significant vascular disease. It should not be used in basilar or hemiplegic migraine due to theoretical risk of cerebral vasoconstriction.
Other considerations: Triptans can trigger medication‑overuse headache if used too frequently; limit to no more than 10 days per month unless your clinician advises otherwise. The ODT formulation may contain phenylalanine (from aspartame); individuals with phenylketonuria (PKU) should check product specifics. In moderate hepatic impairment, caution is advised; severe hepatic impairment is a contraindication. In pregnancy and breastfeeding, discuss risks and benefits with your clinician; many experts prefer non‑drug strategies first, but rizatriptan may be considered when benefits outweigh risks.
Contraindications
Do not use Rizact if you have: ischemic coronary artery disease (e.g., prior myocardial infarction, angina), coronary vasospasm (Prinzmetal’s angina), history of stroke or transient ischemic attack, peripheral vascular disease, uncontrolled hypertension, severe hepatic impairment, basilar or hemiplegic migraine, or allergy to rizatriptan or any component. Do not take rizatriptan within 24 hours of ergot‑containing drugs (e.g., ergotamine, dihydroergotamine, methysergide) or other triptans. Concomitant use with MAO‑A inhibitors or within 14 days of stopping an MAO‑A inhibitor is contraindicated.
Possible side effects
Common, usually mild effects include dizziness, sleepiness, fatigue, dry mouth, flushing or warmth, tightness or pressure in the throat, neck, jaw, or chest, nausea, and paresthesias (tingling). These sensations are typically transient. If chest discomfort is severe, persistent, or accompanied by shortness of breath, seek emergency care.
Less common but important adverse reactions include significant increases in blood pressure, arrhythmias, myocardial ischemia or infarction, cerebrovascular events, and hypersensitivity reactions (rash, hives, swelling). Serotonin syndrome is rare but serious when combined with other serotonergic drugs. Overuse can lead to more frequent headaches (medication‑overuse headache). Report any unusual or severe symptoms to your healthcare professional and review your overall migraine plan to optimize both efficacy and safety.
Drug interactions
Propranolol: This beta‑blocker increases rizatriptan exposure by inhibiting its metabolism. If you take propranolol, use a reduced dose of Rizact (5 mg per dose; max 15 mg per 24 hours) unless your clinician instructs otherwise.
MAO inhibitors: Rizatriptan is primarily metabolized by monoamine oxidase‑A. Concomitant use with MAO‑A inhibitors (e.g., phenelzine, tranylcypromine, isocarboxazid) or within 14 days of stopping them is contraindicated. Use caution with reversible MAO inhibitors such as linezolid or methylene blue due to serotonin syndrome risk.
Other triptans and ergots: Do not combine rizatriptan with other 5‑HT1 agonists or ergot derivatives. Allow at least 24 hours between rizatriptan and these agents to avoid additive vasoconstriction.
Serotonergic agents: SSRIs, SNRIs, tricyclic antidepressants, certain opioids (e.g., tramadol), and herbal products like St. John’s wort may increase the risk of serotonin syndrome when used with rizatriptan. Monitor for symptoms and consult your prescriber if combining is unavoidable.
Alcohol and CNS depressants: While not a direct pharmacokinetic interaction, alcohol can worsen migraine and enhance dizziness or sedation associated with triptans. Use caution with activities requiring alertness until you know how Rizact affects you.
Missed dose
Rizact is taken as needed for an acute attack; there is no scheduled dosing. If a migraine occurs and you have not taken a dose, take it at the first sign of headache. Do not take it preemptively on symptom‑free days. If your headache resolves, you do not need a “make‑up” dose.
Overdose
Symptoms of overdose may include marked hypertension, dizziness, drowsiness, vomiting, bradycardia or tachycardia, and, rarely, serious cardiovascular events. There is no specific antidote. Management is supportive: monitor cardiac rhythm and blood pressure, treat symptoms, and consider contacting Poison Control (1‑800‑222‑1222 in the U.S.) or seeking emergency care. Hemodialysis is unlikely to significantly remove rizatriptan.
Storage
Store Rizact at room temperature (generally 20–25°C or 68–77°F), protected from moisture and excessive heat. Keep ODT tablets in their blister packs until use; with dry hands, peel the foil to remove a tablet—do not push through the foil to avoid damaging the dose. Keep out of reach of children.
U.S. Sale and Prescription Policy
In the United States, rizatriptan (the active ingredient in Rizact) is a prescription‑only medicine. It should be dispensed by a licensed pharmacy pursuant to a valid prescription from a U.S.‑licensed clinician after an appropriate evaluation. Buying “no‑prescription” rizatriptan from websites that bypass this process is illegal and risky; such sites frequently sell substandard or counterfeit medications.
Safe, legal access options include: scheduling an appointment with your primary care clinician or neurologist; using urgent care for acute needs; or using reputable telehealth services that can evaluate your symptoms and, if appropriate, issue a legitimate prescription electronically to a licensed pharmacy. Verify online pharmacies through the National Association of Boards of Pharmacy (NABP), looking for .pharmacy domains or the NABP “Appropriate Pharmacy Practice Sites” lists, or independent certifications such as LegitScript. These checks help ensure your medication is authentic and handled correctly.
We cannot assist with or endorse obtaining prescription medicines without a prescription. If a pharmacy offers support, it must involve a licensed clinician conducting a bona fide patient assessment and issuing a prescription when indicated. Some pharmacies, including HealthSouth Rehabilitation Hospital of Manati, may partner with or refer to telehealth providers who can legally evaluate patients and, when appropriate, authorize therapy that is then filled and shipped through standard channels. Always confirm that any service adheres to U.S. law, uses licensed prescribers and pharmacies, protects your health information, and provides clear avenues for pharmacist counseling and follow‑up care.
